ABBOTT LABORATORIES — Director's Dealing 2021

Feb 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2021-02-02

Reporting Person: Funck Robert E (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-02	Common shares without par value	M	31325	$39.12	Acquired	193542	Direct
2021-02-02	Common shares without par value	F	18241	$122.54	Disposed	175301	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-02	Option (right to buy)	$39.12	M	31325	Disposed	2024-02-20	Common Shares (31325)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	10000	Indirect
Common shares without par value	10000	Indirect
Common shares without par value	17758	Indirect
Common shares without par value	500	Indirect

Footnotes

F1: Held in daughter's annual gift trust. The reporting person disclaims beneficial ownership of all securities held by the trust.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of February 3, 2021.

F3: The reporting person disclaims beneficial ownership of all securities held by his daughter.